Asprosin in Cardiovascular Disease: Mechanistic Insights, Context-Dependent Effects, and Translational Perspectives

Lutfu Askin , Okan Tanriverdi , Veysel Ozgur Baris , Ömer Güler , Sedat Sakalli

Cardiovascular Innovations and Applications ›› 2026, Vol. 11 ›› Issue (1) : 976

PDF (908KB)
Cardiovascular Innovations and Applications ›› 2026, Vol. 11 ›› Issue (1) :976 DOI: 10.15212/CVIA.2026.0012
Original article
research-article
Asprosin in Cardiovascular Disease: Mechanistic Insights, Context-Dependent Effects, and Translational Perspectives
Author information +
History +
PDF (908KB)

Cite this article

Download citation ▾
Lutfu Askin, Okan Tanriverdi, Veysel Ozgur Baris, Ömer Güler, Sedat Sakalli. Asprosin in Cardiovascular Disease: Mechanistic Insights, Context-Dependent Effects, and Translational Perspectives. Cardiovascular Innovations and Applications, 2026, 11 (1) : 976 DOI:10.15212/CVIA.2026.0012

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, et al.. Asprosin a fasting-induced glucogenic protein hormone. Cell. 2016. Vol. 165(3):566-79

[2]

Karapınar Göze E, Ürün Ünal B, Ünlü A, Açılan İ. Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetes. Sci Rep. 2026. Vol. 16(1):7745

[3]

Wang X, Zhang X, Tang H, Su X, Ding S, Li X, et al.. Asprosin protects H9C2 cells from ferroptosis following hypoxia/reoxygenation by promoting mitophagy. Cardiovasc Ther. 2026. Vol. 2026:8401037

[4]

Lima Sobrinho JAB, Almeida MQ. cAMP/PKA signaling in endocrine hypertension: genetic mechanisms and pathophysiological insights. Front Endocrinol (Lausanne). 2026. Vol. 17:1748702

[5]

Li R, Ma J, Li M, Zeng B, Li X, Bi X, et al.. Panax notoginseng saponins ameliorate high-fat diet-induced liver injury via mechanisms involving TLR4-mediated signaling and lipid metabolism. Food Sci Nutr. 2026. Vol. 14(2):e71544

[6]

Islam MR, Alam R, Islam F, Nagar P, Rahman MA. Mitochondrial antioxidant enzyme (SOD2) at the crossroads of redox signaling and cancer progression. Free Radic Res. 2026. 1-18

[7]

Sazdova I, Gagov H, Hadzi-Petrushev N, Konaktchieva M, Konakchieva R, Mladenov M. Advanced studies in molecular and metabolic mechanisms of diabetes: pathogenic crosstalk, biomarkers, and translational therapeutics. Appl Sci. 2026. Vol. 16(6):3027

[8]

Alkhalidy H, Assamak A, Al-Shami I, Mukattash TL, Khashman T, Liu D. Elevated asprosin in hypertension: evidence from an exploratory case-control study. Sci Rep. 2026. Vol. 16(1):2973

[9]

Aslan G, Bulmus O, Tuzcu M, Gökdere E, Can Sahna K, Sahin K, et al.. The protective effects of melatonin postconditioning in cerebral ischemia may be mediated through the modulation of FUNDC1 and Bnip 3 levels. Brain Inj. 2026. 1-11

[10]

Wang X, Ginting CN, Leslie W. Identification of potential hub genes related to ferroptosis and hypoxia in dilated cardiomyopathy: a bioinformatic analysis with preliminary experimental validation. Exp Biol Med (Maywood). 2026. Vol. 251:10709

[11]

Meng F, Zi Y, Han C, Zhao M, Wang L, Chang L, et al.. The asp-encoding gene FBN1 mediates cold adaptation in Sunite sheep by reprogramming adipocyte differentiation towards thermogenesis. Cells. 2026. Vol. 15(4):329

[12]

Megahed SA, Kaiser HH, Abdelmageed AIH, Allam AS. Changes in asprosin and adiponectin serum level in non-alcoholic fatty liver disease. Al-Azhar Intern Med J. 2026. 100-4

[13]

Goldberg D, Goldstein I. Endocrine regulation of the hepatic fasting response: cues, cooperation and consequences. Nat Rev Endocrinol. 2026. Vol. 22(5):302-16

PDF (908KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/